Kinnate Biopharma Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19
	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Selling, general and administrative [+]	30.4	22.9	6.8
General and administrative	30.4	22.9	6.8
Research and development	88.2	67.2	29.2
EBITDA [+]	-117.9	-90.0	-35.9
EBITDA growth	31.0%	150.5%
Depreciation and amortization	0.6	0.1	0.1
EBIT [+]	-118.5	-90.1	-36.0
EBIT growth	31.5%	150.3%
Other income (expense), net [+]	2.3	0.3	0.2
Other			0.2
Pre-tax income	-116.3	-89.8	-35.8
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-116.3	-89.8	-35.8

Basic EPS [+]	($2.64)	($2.06)	($5.28)
Growth	28.2%	-61.0%
Diluted EPS [+]	($2.64)	($2.06)	($5.28)
Growth	28.2%	-61.0%

Shares outstanding (basic) [+]	44.1	43.6	6.8
Growth	1.1%	544.3%
Shares outstanding (diluted) [+]	44.1	43.6	6.8
Growth	1.1%	544.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.